Charles River Laboratories CRL Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's financing cash flow?
- Charles River Laboratories (CRL) reported financing cash flow of $347.72M in Q1 2026.
- How has Charles River Laboratories's financing cash flow changed year-over-year?
- Charles River Laboratories's financing cash flow increased by 430.1% year-over-year, from -$105.33M to $347.72M.
- What is the long-term trend for Charles River Laboratories's financing cash flow?
- Over 2 years (2022 to 2025), Charles River Laboratories's financing cash flow has grown at a 255.8% compound annual growth rate (CAGR), from -$42.4M to -$536.73M.
- What does financing cash flow mean?
- The net change in cash resulting from transactions with shareholders and lenders.
- How do you interpret financing cash flow?
- Negative values often indicate debt repayment or share buybacks, while positive values suggest net borrowing or equity issuance.
- How does financing cash flow compare across companies?
- Highly dependent on the company's current stage in the capital cycle.